Drawing for PERSONALIZE MY TREATMENT (PMT)

USPTO serial 90226501

PERSONALIZE MY TREATMENT (PMT)

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARCY, AMY ALFIERI
Law office
TMEG LAW OFFICE 109

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PERSONALIZE MY TREATMENT (PMT)?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria NOTARO, MICHALOS & ZACCARIA P.C.100 DUTCH HILL ROAD, SUITE 240ORANGEBURG, NY 10962UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Platform as a service (PAAS) featuring computer software platforms in the field of oncology, for matching cancer patients to biology driven clinical trials based on the molecular profile of their tumour; providing an on-line computer database in the field of medical and scientific research information in the field of clinical trials, featuring medical and scientific research information pertaining to a patient's molecular, clinical, epidemiological data and research findings for use in silico trial design, for matching cancer patients to clinical trials and for studying health econometrics; providing an on-line computer database in the field of medical and scientific research as it pertains to cancer treatment, diagnosis and molecular profilingACTIVE—
044Biobank services in the nature of providing access to a bank of human blood, biological and tissue samples for cancer patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 3, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 3, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 7, 2025GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 7, 2025GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 7, 2025CNSISUSPENSION INQUIRY WRITTEN—
Mar 7, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 7, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Mar 7, 2024CNSLSUSPENSION LETTER WRITTEN—
Jan 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 7, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 7, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 7, 2023CNSISUSPENSION INQUIRY WRITTEN—
Apr 21, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 21, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Apr 21, 2023CNSLSUSPENSION LETTER WRITTEN—
Apr 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2023ALIEASSIGNED TO LIE—
Apr 12, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 27, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 27, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 27, 2023CNSISUSPENSION INQUIRY WRITTEN—
Jul 15, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 15, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Jul 15, 2022CNSLSUSPENSION LETTER WRITTEN—
Jun 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 28, 2022ALIEASSIGNED TO LIE—
May 25, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 28, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 28, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 28, 2021CNSISUSPENSION INQUIRY WRITTEN—
Oct 27, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 19, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 19, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Apr 19, 2021CNSLSUSPENSION LETTER WRITTEN—
Mar 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2021DOCKASSIGNED TO EXAMINER—
Nov 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance